FDA and EMA Just Changed AI Validation Rules — Pharma Compliance Is Shifting Fast

FDA and EMA have jointly released a new set of principles for the use of artificial intelligence in drug development, marking a major regulatory shift in how AI systems must be designed, validated, and governed in pharmaceutical environments.